RSL3 | GPX4 inhibitor/Ferroptosis inducer

CAS:
1219810-16-8
Catalog Number:
10-3417
Activity:
GPX4 inhibitor/Ferroptosis inducer
Chemical Names:
(1S,3R)-Methyl 2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1-[4-(methoxycarbonyl)phenyl]-1H-pyrido[3,4-b]indole-3-carboxylate
Alternate Name:
1S,3R-RSL3
Molecular Weight:
440.88
Molecular Formula:
C23H21ClN2O5
Solubility:
Soluble in DMSO (45 mg/ml)
Physical Properties:
Off-white solid
Purity:
>98% HPLC
NMR (Conforms)
Storage Temperature:
-20°C
Stability:
Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
Shipping Code:
RT

Available Options

Size:PriceQuantity 
5 mg$85.00
25 mg$250.00
Request bulk quote / custom size
Product Inquiry

RSL3 (1219810-16-8) Inhibits glutathione peroxidase (GPX4) inducing ferroptosis.1,2  Effectively induces ferroptosis in glioblastoma cells.3  Everolimus in combination with RSL3 synergistically inhibits the viability of renal cell carcinoma (RCC) cells suggesting a mechanism by which RCC drug resistance may be overcome.4

References/Citations:

  1. Yang et al. (2014), Regulation of ferroptotic cancer cell death by GPX4; Cell 156 317
  2. Kagan et al. (2017), Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis; nAT. Chem. Biol. 13 81
  3. Shengbiao et al. (2021), RSL3 Drives Ferroptosis through NF-kB Pathway Activation and GPX4 depletion in Glioblastoma; oXID. Med. Cell. Longev. 2021 2915019
  4. Yangyun et al. (2022), Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma; Gene 809 145992
CAS:
1219810-16-8
Catalog Number:
10-3417
Activity:
GPX4 inhibitor/Ferroptosis inducer
Chemical Names:
(1S,3R)-Methyl 2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1-[4-(methoxycarbonyl)phenyl]-1H-pyrido[3,4-b]indole-3-carboxylate
Alternate Name:
1S,3R-RSL3
Molecular Weight:
440.88
Molecular Formula:
C23H21ClN2O5
Solubility:
Soluble in DMSO (45 mg/ml)
Physical Properties:
Off-white solid
Purity:
>98% HPLC
NMR (Conforms)
Storage Temperature:
-20°C
Stability:
Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
Shipping Code:
RT

Safety Data Sheet:

N/A

Product Data Sheet:

Download Product Data Sheet

Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee

RSL3 (1219810-16-8) Inhibits glutathione peroxidase (GPX4) inducing ferroptosis.1,2  Effectively induces ferroptosis in glioblastoma cells.3  Everolimus in combination with RSL3 synergistically inhibits the viability of renal cell carcinoma (RCC) cells suggesting a mechanism by which RCC drug resistance may be overcome.4

References/Citations:

  1. Yang et al. (2014), Regulation of ferroptotic cancer cell death by GPX4; Cell 156 317
  2. Kagan et al. (2017), Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis; nAT. Chem. Biol. 13 81
  3. Shengbiao et al. (2021), RSL3 Drives Ferroptosis through NF-kB Pathway Activation and GPX4 depletion in Glioblastoma; oXID. Med. Cell. Longev. 2021 2915019
  4. Yangyun et al. (2022), Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma; Gene 809 145992

Focus Biomolecules • Plymouth Meeting, PA USA • 1-855-FOCUS21

Focus Biomolecules
Plymouth Meeting, PA USA
1-855-FOCUS21

Menu
Menu
Menu
Menu
VIEW DISTRIBUTORS LIST
Facebook Twitter Linkedin
Menu
Menu

Website Created by Advanta Advertising LLC.